in pictures and a few words
What it is and why
Cordyceps is a fungus from Tibetan and Chinese folk medicine. It grows inside a living insect larva and comes out as a stalk.
- It is not one fungus but hundreds of species with different makeup
- Fungus from a mountain meadow and mycelium grown in a tank are different products
- A large review gathered what is known about its effects on the body
Immunity: both ways
The fungus’s substances can both boost the body’s defenses and hold them back when they are too strong. So it is more accurate to call it not a “stimulant” but a tuner of immunity.
- This is what experiments on cells and animals showed
- When the kidneys work poorly, it is described as improving immunity
- After a kidney transplant, as an inexpensive way to hold immunity back
Important. After an organ transplant, taking cordyceps must be discussed with your treating doctor.
Endurance in older people
Healthy older people took a product made from cordyceps mycelium, others took a dummy pill. In those who took the product, exercise thresholds rose.
- According to the review, this means the body copes better with exertion without tiring
- This is the strongest result in people in the review by how it was set up
- Mice given substances from the mycelium swam longer before exhaustion
Kidneys
Most of the studies with patients in the review are about the kidneys.
- In long-term kidney disease, when the kidneys work poorly, better function is described
- After a kidney transplant, less blood and protein in the urine
- In older people, kidney protection from one group of antibiotics
Inflammation and tumors
In experiments on cells and animals, the fungus’s substances reduced inflammation.
- Less swelling, and in bowel inflammation less diarrhea and bleeding
- In lab experiments, one of the fungus’s substances slowed the division of cancer cells
Important. If you are receiving chemotherapy, discuss taking cordyceps with your doctor in advance.
Sugar, fats and blood pressure
In mice and rats, the fungus’s substances lowered blood sugar, blood fats and blood pressure.
- Sensitivity to insulin, the hormone that lowers sugar, went up
- When given by mouth, sugar fell only slightly
Important. If you take blood thinners or drugs that lower sugar or blood pressure, discuss it with your doctor: the effects may add up.
How to choose
“Cordyceps” on a package without the species name tells you little. Each species has its own makeup.
- The fungus itself has more protein and some other substances than mycelium
- There is no single dose: folk medicine finds it by trial and error
Who should see a doctor first
If you already take cordyceps or are thinking about it, tell your doctor. Especially in these cases:
- A transplanted organ or drugs that suppress immunity
- Chemotherapy, prostate cancer or suspected prostate cancer
- Blood thinners, drugs for sugar or blood pressure; hormone-dependent diseases
Important. The fungus’s substances may change how drugs work, so discuss this with your doctor before you start.
What is known about safety
The review authors write that in most cases no side effects were reported. But “not reported” does not yet mean “safe.”
- In one species of the fungus, a substance that suppresses immunity was found
- In mice, the fungus sped up the growth of prostate cancer
- Men with prostate cancer or suspected prostate cancer should discuss it with a doctor
In one sentence
In experiments, cordyceps substances both boost and hold back immunity, and in healthy older people one mycelium product raised endurance thresholds. Start with the species name and a talk with your doctor.
Key points
Cordyceps is an insect-parasitizing fungus from Tibetan and traditional Chinese medicine; what its compounds do and where each result was obtained is set out in the review Das G, Front Pharmacol 2021 and in the table below.
| Area | How it helps | What studies in humans showed |
|---|---|---|
| Immunity | the fungus’s compounds both enhance the immune response and restrain an excessive one — an immunomodulator [preclinical] | renal failure: better cellular immunity; after kidney transplant, a “cost-effective immunosuppressive agent” [humans · design not described] |
| Endurance | mice given C. sinensis mycelium polysaccharides swam longer to exhaustion [animals] | Cs-4, 12 weeks, healthy older adults: higher metabolic and ventilatory thresholds [humans · placebo-controlled] |
| Kidneys | kidney function was preserved in mice with type 2 diabetes [animals] | chronic renal failure: improved kidney function; after kidney transplant, less blood and protein in the urine; in older patients, kidney protection from aminoglycoside antibiotics [humans · design not described] |
| Inflammation | less edema and fewer signs of colitis; lower NO, prostaglandin E2 and proinflammatory cytokines [animals · in vitro] | — |
| Tumors | cordycepin inhibits cancer cell proliferation; at low concentration it increased the sensitivity of gallbladder cancer cells to chemotherapy drugs [in vitro · animals] | — |
| Blood sugar, lipids, blood pressure | lower glucose and insulin, higher insulin sensitivity, lower lipids and blood pressure [animals] | — |
| Male fertility | better sperm motility and morphology in boars and rats [animals] | — |
How it helps
How to read the labels
A label follows every statement about an effect on the body: it tells you in whom or in what the result was obtained. The closer a label is to the word “humans,” the closer the result is to the question “will this help me.” An RCT is a randomized controlled trial: groups are assigned at random; in a placebo-controlled trial the comparison is with a dummy pill.
| Label | What it means |
|---|---|
| [traditional use] | folk use; experience, not testing |
| [chemical analysis] | what was found in the fungus; says nothing about the effect |
| [in vitro] | cells in a test tube or dish |
| [in vitro · human cells] | human cells, but the experiment is in a test tube |
| [animals] | mice, rats and other animals |
| [preclinical] | cells and/or animals; the review does not specify |
| [humans · design not described] | people took part; the design is not reported |
| [humans · RCT] or [humans · placebo-controlled] | controlled trials |
| [review authors’ opinion] | an assumption, not the result of an experiment |
| [level not stated] | not said in whom it was obtained |
What is inside
The fungus contains dozens of groups of substances: nucleosides, sterols, flavonoids, cyclic peptides, phenolics, alkaloids, polysaccharides and others.
- Cordycepin (3′-deoxyadenosine) is an almost exact copy of adenosine, missing one oxygen atom; it is notably abundant in C. militaris. [chemical analysis]
- Because of its resemblance to adenosine, cordycepin is linked to intracellular targets, apoptosis and the cell cycle (Tuli et al., 2013b). [preclinical]
- “Cordycepic acid” is in fact D-mannitol; C. sinensis contains 7–29% of it, depending on the growth stage. [chemical analysis] It is credited with effects in liver fibrosis, a diuretic effect and free-radical-scavenging properties. [level not stated]
- Polysaccharides make up 3–8% of the fruiting body. Only β-(1→3)-glucan, galactosaminoglycan and proteopolysaccharide showed antitumor activity. [level not stated]
- A polysaccharide fraction of C. sinensis mycelium switches macrophages from the M2 type (“healing”) to the M1 type (“attack”) via NF-κB (Chen W et al., 2010; 2012). [in vitro]
Immunity
The main topic of the review. Cordyceps, its extracts and compounds have been linked to production of the cytokines IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12 and TNF-α. [preclinical] It has also been linked to enhanced phagocytosis, nitric oxide production via the enzyme iNOS, triggering of the inflammatory response via the MAPK signaling pathway and synergism with interferon-γ in cytokine production. [preclinical]
| Enhances | Restrains |
|---|---|
| cytokines IL-1β, IL-6, TNF-α ↑ | NO, TNF-α, IL-12 ↓ |
| phagocytosis ↑ | T-cell proliferation ↓ |
| NK cells ↑ | immunosuppression after kidney transplant |
- C. militaris polysaccharides in mice with cyclophosphamide-suppressed immunity: lymphocyte proliferation and the phagocytic index increased (Wang M et al., 2012). [animals]
- An acidic polysaccharide of C. militaris given intranasally to mice with influenza A: less virus in the lungs, higher survival; the same polysaccharide increased TNF-α, IFN-γ and NO in macrophages (Ohta et al., 2007). [animals · in vitro]
- Methanol fractions of C. sinensis suppressed lymphocyte proliferation, NK cell activity and IL-2 and TNF-α production by human mononuclear cells (Kuo et al., 1996). [in vitro · human cells]
- Aqueous extract of C. militaris suppressed NO, TNF-α and IL-6 production by activated macrophages (Jo et al., 2010). [in vitro]
- Cordycepin and C. sinensis in human cells: at rest, IL-1β, IL-6, IL-8, IL-10 and TNF-α rise; after activation with PHA (phytohemagglutinin, a substance used in the laboratory to activate lymphocytes), IL-2, IL-4, IL-5, IL-12, IFN-γ and TNF-α fall (Zhou et al., 2008). [in vitro · human cells]
In humans, C. sinensis is described as improving cellular immunity in renal failure (Guan et al., 1992) and as a “cost-effective immunosuppressive agent” after kidney transplantation (Li et al., 2009). [humans · design not described] Respiratory infections (Lin, Li, 2011) are mentioned with a book as the source. [level not stated]
Jung et al., 2019: CBG-CS-2 mycelium (Paecilomyces hepiali), healthy adults, Korea; randomized and double-blind, according to its title in the reference list. [humans · RCT] The review reports that the trial assessed efficacy and safety. Separately, the review writes that CBG-CS-2 components enhance NK cell activity and phagocytosis. [level not stated]
Endurance
Cs-4 (C. sinensis) for 12 weeks in healthy older adults, a double-blind, placebo-controlled trial (Chen S et al., 2010): higher metabolic and ventilatory thresholds. [humans · placebo-controlled] According to the review, higher thresholds indicate better aerobic performance without fatigue in older people. This is the review’s strongest result by design among those with a described outcome.
Xiao et al., 1999: according to its title in the reference list, increased aerobic capacity in healthy older adults on Cs-4 (an abstract). [humans · design not described] The fungus’s reputation in sports: in 1993 world athletics champions spoke of a diet that included cordyceps (Kashyap et al., 2016). [level not stated]
- Mice given C. sinensis mycelium polysaccharides swam longer to exhaustion (Li & Li, 2009; Yan et al., 2012). [animals]
- Benefits “have also been observed in athletes”: the review attributes them to a rise in cellular ATP. [review authors’ opinion]
Kidneys
- Kidney transplant patients (per the study title), long-term C. sinensis: less blood and protein in the urine (Ding et al., 2011). [humans · design not described]
- Older patients (per the study title): kidney protection from aminoglycoside antibiotics (Bao et al., 1994). [humans · design not described]
- Chronic renal failure: improved kidney function (Guan et al., 1992). [humans · design not described]
- CmNo1 (fruiting body and mycelium of C. militaris) preserved kidney function in mice with type 2 diabetes (Yu et al., 2016). [animals]
Inflammation
- Ethanol extract of C. militaris mycelium reduced carrageenan-induced edema and iNOS expression in macrophages (Won & Park, 2005). [animals · in vitro]
- Aqueous extract of C. militaris in dextran sulfate–induced colitis: less weight loss, diarrhea, bleeding and mucosal damage (Han et al., 2011). [animals]
- Cordycepin in BV2 microglial cells dose-dependently reduced NO, prostaglandin E2 and proinflammatory cytokines (Jeong et al., 2010). [in vitro] From these data the authors speak of “high potential” in neurodegenerative diseases. [review authors’ opinion]
- C. sinensis compounds suppressed the release of superoxide anion and elastase by human neutrophils: IC50 0.45 and 1.68 μg/mL versus 38.32 and 31.98 for indomethacin, an anti-inflammatory drug used as the control (Yang et al., 2011). “Most of the compounds” outperformed indomethacin; the values are as given in the review. [in vitro · human cells] IC50 is the concentration at which the effect is inhibited by half: the smaller the number, the stronger the compound in a test tube.
- A C. sinensis polysaccharide in tumor-bearing mice increased SOD and GPx (enzymes that neutralize free radicals) and lowered MDA, a marker of radical damage to fats (Chen et al., 2006). [animals]
Tumors and infections
- Cordycepin inhibits cancer cell proliferation via A3 adenosine receptors and the Wnt pathway (Yoshikawa et al., 2004–2008). [in vitro · animals] As the review stresses, cordycepin acts through pathways “depending upon the cell type.”
- At low concentration, cordycepin increased the sensitivity of gallbladder cancer cells to gemcitabine and 5-fluorouracil (Wu et al., 2014). [in vitro]
- C. militaris inhibited the growth of T-cell lymphoma transplanted into mice (Park et al., 2017). [animals]
- Individual compounds from different species inhibited E. coli, the malaria parasite Plasmodium, Mycobacterium tuberculosis and HIV-1 reverse transcriptase. [in vitro]
Blood sugar, lipids, blood pressure
- A polysaccharide of C. sinensis mycelium lowered plasma glucose in mice when injected into the abdominal cavity; with oral intake the lowering was “slight” (Kiho et al., 1993). [animals]
- CordyMax Cs-4 in rats: lower basal glucose and insulin, higher insulin sensitivity (Balon et al., 2002; Zhao et al., 2002). [animals]
- A protein component of C. sinensis lowered mean arterial pressure in rats (Chiou et al., 2000). [animals]
- A C. militaris polysaccharide lowered blood and liver lipids (Wang L et al., 2015). [animals]
Memory and mood
- In old mice, C. sinensis improved learning and memory (Wang et al., 2004). [animals]
- A supercritical extract of C. sinensis had an antidepressant-like effect in the mouse tail suspension test (Nishizawa et al., 2007). [animals]
Hormones and fertility
- Cordyceps is called “Himalayan Viagra” in popular literature (Kashyap et al., 2016). [traditional use]
- C. militaris mycelium improved sperm motility and morphology in subfertile boars and in rats (Lin et al., 2007; Chang et al., 2008). [animals]
- Cordycepin increased testosterone in Leydig cells and in mouse plasma (Leu et al., 2011). [in vitro · animals]
- In human granulosa cells, C. sinensis increased estradiol production (Huang B M et al., 2004). [in vitro · human cells]
In traditional medicine
The fungus is used in the folk medicine of Tibet, China, Nepal, Bhutan and India; in 1964 it was listed in the Chinese Pharmacopoeia.
- In traditional Chinese medicine (TCM), a tonic for diseases of the respiratory tract, liver and kidneys, for high blood sugar and for tumors. [traditional use]
- For energy, endurance, aerobic capacity and “cellular immunity”; for fatigue and weakness, and to ease the symptoms of altitude sickness. [traditional use]
- TCM practitioners recommend regular intake of C. sinensis “to avoid infections, colds, and flues,” and for cough, asthma and bronchial diseases. [traditional use]
How to choose and take it
“Cordyceps” is not one fungus but hundreds of species with different compositions: the genus has more than 700. About 20 parasitize Elaphomyces fungi; the rest parasitize insects and arachnids. It grows in the mountains at 3,600–4,000 m. The best-studied species are C. sinensis (current name Ophiocordyceps sinensis) and C. militaris.
The fungus develops inside a living larva, replaces its tissues and emerges as a stalk, the fruiting body. Because of overharvesting the wild fungus has become scarce; since the 1970s scientists have been looking for ways to ferment and cultivate it, and C. militaris is considered a cheaper substitute for C. sinensis. Fungus from a mountain meadow and mycelium (the network of fungal threads) from a fermenter are different products. The review describes C. sinensis as a dietary supplement that complies with the requirements of the FDA, the US Food and Drug Administration (Wu et al., 2015): this refers to dietary supplement requirements, not to a proven therapeutic effect.
Each species has its own folk “specialty,” so the word “cordyceps” on a package without the species name tells you little.
| Part of the fungus | Ergosterol, mg/g | Protein, % |
|---|---|---|
| Mycelium | 1.44 | 14.8 (fermenter) |
| Fruiting body | 10.68 | 30.4 |
| Dead larvae | — | 29.1 |
Tradition has no single dose: local healers choose the dose and route “by trial and error” (Maity, 2013). [traditional use]
Who should see a doctor first
If you take immunosuppressants or have a transplanted organ, discuss taking cordyceps with your treating physician. If you are receiving chemotherapy, discuss taking cordyceps with your treating physician in advance. The same applies if you take blood thinners, glucose-lowering or blood pressure–lowering drugs: such combinations in humans were not studied in the review. Men with prostate cancer, or with suspected prostate cancer, should discuss taking cordyceps with their physician.
If you have a hormone-dependent condition, discuss taking cordyceps with your physician.
If you already take cordyceps or are considering it, tell your treating physician, especially if you have any of the conditions listed.
Combination with drugs
- C. sinensis together with cyclosporin A in kidney transplantation (Ding et al., 2009). [level not stated]
- Cordycepin increased the sensitivity of cancer cells to gemcitabine and 5-fluorouracil. [in vitro]
- Polysaccharides with chemotherapy drugs: “synergism.” [animals]
- Among the proposed applications of cordyceps, the review lists anti-thrombotic and anticoagulant effects (Qian et al., 2012; Liu Y et al., 2015). [level not stated]
- Lowering of blood sugar in mice and rats, and of mean arterial pressure in rats. [animals]
The review gives no data on drug interactions in humans. But everything listed is a signal that the fungus’s components may alter how drugs work. If blood-thinning, glucose-lowering and blood pressure–lowering effects exist in humans, they may add to the action of drugs with the same purpose.
What is known about safety
- “These properties are concentration-dependent, and in most cases, no adverse effects were reported, although the evaluation of isolated compounds such as cordycepin is preferred.” [review authors’ opinion]
- The only RCT (Jung et al., 2019) also assessed safety, but the review gives no data on adverse effects. [humans · RCT]
- Not all of the substances found are “beneficial”: they include immunosuppressants. Cyclosporin has been found in the species Cordyceps subsessilis (Segelken, 1996). [chemical analysis] C. sinensis has been used as a “cost-effective immunosuppressive agent” after kidney transplantation (Li et al., 2009). [humans · design not described]
- In mice, C. sinensis increased testosterone and the androgen receptor and accelerated the growth of prostate cancer cells (Ma et al., 2018). [animals] In LNCaP human prostate cancer cells, apoptosis and autophagy have been described (Lee et al., 2014). [in vitro · human cells] The data contradict each other, and cell experiments do not show what will happen when a person takes the fungus.
- Rugulosin and skyrin from C. formosana in CHO cells (a non-tumor line from Chinese hamster ovary): LD50 18.3 ± 0.2 and 103.7 ± 5.9 μg/mL (Lu et al., 2014). [in vitro] LD50 is the dose that kills half of the test subjects.
- “New toxicological studies are needed to ensure their safety.” [review authors’ opinion]
Bottom line
Cordyceps is a fungus of Tibetan and traditional Chinese medicine with dozens of groups of substances: cordycepin, polysaccharides, sterols and others. The Das et al., 2021 review has collected a broad map of its effects: in cells and animals the fungus’s compounds both enhance and restrain the immune response, reduce inflammation, inhibit cancer cell proliferation and lower blood sugar, lipids and blood pressure [preclinical]; in humans, higher endurance thresholds in healthy older adults on Cs-4 [humans · placebo-controlled] and studies with kidney patients [humans · design not described]. If you have any of the conditions in “Who should see a doctor first,” discuss taking it with your physician first.
The full guide is 89 pages laid out for a phone screen: all nine sections, a glossary and the list of human studies from the review — download the PDF.
Read also the second guide, Cordyceps and Arrhythmias: A Review of Wang et al., 2022, and the article on why wild Himalayan and lab-grown cordyceps are two different products.
References
- Das G, Front Pharmacol 2021. PMID 33628175
Key facts
- Cordyceps is an immunomodulator: according to the Das et al., 2021 review, the fungus’s compounds in cell and animal experiments both enhance the immune response (cytokines, phagocytosis, NK cells) and restrain an excessive one [preclinical]
- Cs-4 (a mycelial fermentation product of C. sinensis) for 12 weeks in healthy older adults, a double-blind, placebo-controlled trial: higher metabolic and ventilatory thresholds, the review’s strongest result by design [humans · placebo-controlled]
- In studies with patients, C. sinensis is linked to improved kidney function in chronic renal failure, less blood and protein in the urine after kidney transplantation and better cellular immunity in renal failure [humans · design not described]
- Cordycepin, polysaccharides and extracts of the fungus reduced inflammation, inhibited cancer cell proliferation and lowered glucose, lipids and blood pressure in cells and animals [in vitro · animals]
- Taking cordyceps should be discussed with a physician in advance after organ transplantation and when taking immunosuppressants, during chemotherapy, with prostate cancer or suspected prostate cancer, when taking blood thinners, glucose-lowering or blood pressure–lowering drugs, and with hormone-dependent conditions





